BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33738476)

  • 1. Over-prescription of short-acting beta agonists in the treatment of asthma.
    Looijmans-van den Akker I; Werkhoven A; Verheij T
    Fam Pract; 2021 Sep; 38(5):612-616. PubMed ID: 33738476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of excessive short-acting β
    Kupczyk M; Barg W; Bochenek G; Brożek G; D Browiecki P; Brzostek D; D Browski A; Dobek R; Gawlik R; Kucharczyk A; Kupryś-Lipińska I; Mastalerz-Migas A; Kowalski ML
    Postepy Dermatol Alergol; 2023 Dec; 40(6):790-797. PubMed ID: 38282873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-acting β
    Yorgancıoğlu A; Aksu K; Naycı SA; Ediger D; Mungan D; Gül U; Beekman MJHI;
    BMC Pulm Med; 2022 Jun; 22(1):216. PubMed ID: 35655251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-prescription of short-acting β
    Chakaya J; Mecha J; Beekman M
    BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-acting β
    Theerakittikul T; Nakwan N; Niyompattama A; Siriphan P; Beekman MJHI
    J Asthma; 2023 Dec; 60(12):2177-2188. PubMed ID: 37405933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-prescription of short-acting β
    Khattab A; Madkour A; Ambaram A; Smith C; Muhwa CJ; Mecha JO; Alsayed M; Beekman MJHI
    Curr Med Res Opin; 2022 Nov; 38(11):1983-1995. PubMed ID: 36031882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SABINA: An Overview of Short-Acting β
    Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF
    Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Short-Acting β
    Price D; Jenkins C; Hancock K; Vella R; Heraud F; Le Cheng P; Murray R; Beekman M; Bosnic-Anticevich S; Botini F; Carter V; Catanzariti A; Doan J; Fletton K; Kichkin A; Le T; Le Lievre C; Lau CM; Novic D; Pakos J; Ranasinghe K; Roussos A; Samuel-King J; Sharma A; Stewart D; Willet B; Bateman E;
    Adv Ther; 2024 Mar; 41(3):1262-1283. PubMed ID: 38310584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the overuse of short-acting β2-agonists on the risk of sepsis and septic shock.
    Lai CC; Chen CH; Wang YH; Wang CY; Wang HC
    J Allergy Clin Immunol; 2022 Jul; 150(1):75-81.e1. PubMed ID: 35108605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overprescription of short-acting β
    Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
    Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usage Patterns of Short-Acting β
    Amin S; Soliman M; McIvor A; Cave A; Cabrera C
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2556-2564.e8. PubMed ID: 32244024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-prescription of short-acting β
    Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI
    Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of electronic alerts in primary care computer systems to identify the excessive prescription of short-acting beta
    McKibben S; De Simoni A; Bush A; Thomas M; Griffiths C
    NPJ Prim Care Respir Med; 2018 Apr; 28(1):14. PubMed ID: 29662064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cross-Sectional Study on Prescription Patterns of Short-Acting β
    Pedrozo-Pupo JC; Pacheco Gallego MC; Baños Álvarez IJ; Jaller Raad RA; Caballero Pinilla AC; Reynales Londoño H; Bernal Villada L; Beekman M
    J Asthma Allergy; 2022; 15():1167-1178. PubMed ID: 36051434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.
    Wong MD; Manley RT; Stettin G; Chen W; Salmun LM
    Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study.
    Tavakoli H; Mark FitzGerald J; Lynd LD; Sadatsafavi M
    BMC Pulm Med; 2018 Feb; 18(1):33. PubMed ID: 29433489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has Asthma Medication Use Caught Up With the Evidence?: A 12-Year Population-Based Study of Trends.
    Sadatsafavi M; Tavakoli H; Lynd L; FitzGerald JM
    Chest; 2017 Mar; 151(3):612-618. PubMed ID: 27815152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Tossing a coin:" defining the excessive use of short-acting beta
    McKibben S; Bush A; Thomas M; Griffiths C
    NPJ Prim Care Respir Med; 2018 Jul; 28(1):26. PubMed ID: 30022059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.